Dr. Silmara de Lima joined the University of Pittsburgh after serving as a Senior Staff Scientist at Boston Children’s Hospital and Harvard University. Dr. de Lima’s research focus is optic nerve and retinal regeneration. She first began studying the retina in graduate school as a way to gain more insight into the central nervous system. Dr. de Lima has continued this pursuit throughout her career, combining a background in neuroscience with a focus on oncology and tumor growth.
Dr. de Lima studies optic nerve regeneration through three major projects. She is particularly interested in testing treatments that have been proven effective for other disorders in mice with neuro fibromatosis type 1. She is also investigating treatments in human cells created with an in vitro model using organoids, assembloids, and iPS cells. Additionally, Dr. de Lima studies how axons create a wrap that makes them more adaptable when regenerating by speeding up the travel of electrical currents, a process called myelination.
Dr. de Lima also developed a data analysis technique to study how the optic nerve can regenerate after injury or disease. She led the first study that showed that it was possible for mouse axons in the retina to “regrow lengthy axons, reconnect with subcortical visual targets and improve simple visual behaviors.” She contributed to a study that was the first to show “that regenerating axons from the optic nerve become myelinated.”
- Postdoctoral training, Boston Children’s Hospital/Harvard Medical School, Boston
- PhD in Neuroscience, UFRJ/ICB – Brazil and Boston Children’s Hospital/Harvard Medical School, USA
- Master of Science, Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Ciência Biomédica (ICB) – Brazil
Education & Training
Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors. de Lima S, Koriyama Y, Kurimoto T, Oliveira JT, Yin Y, Li Y, Gilbert HY, Fagiolini M, Martinez AM, Benowitz L. Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9149-54. doi: 10.1073/pnas.1119449109. Epub 2012 May 21.
Combinatorial therapy stimulates long-distance regeneration, target reinnervation, and partial recovery of vision after optic nerve injury in mice. de Lima S, Habboub G, Benowitz LI .Int Rev Neurobiol. 2012;106:153-72. doi: 10.1016/B978-0-12-407178-0.00007-7.
Reassembly of Excitable Domains after CNS Axon Regeneration. Marin MA, de Lima S, Gilbert HY, Giger RJ, Benowitz L, Rasband MN. J Neurosci. 2016 Aug 31;36(35):9148-60. doi: 10.1523/JNEUROSCI.1747-16.2016.
Rescuing axons from degeneration does not affect retinal ganglion cell death. De Lima S, et al. Braz J Med Biol Res. 2016;49(4):e5106. doi: 10.1590/1414-431X20155106. Epub 2016 Mar 18.
Editorial: Promoting nervous system regeneration by treatments targeting neuron-glia interactions. De Lima S, Mietto BS, Ribas VT, Ribeiro-Resende VT, Oliveira ALR, Park KK. Front Cell Neurosci. 2024 Jan 11;17:1355469. doi: 10.3389/fncel.2023.1355469. eCollection 2023.
- Glaucoma
- Neurofibromatosis type 1 – optic pathway glioma
- AMD
- Retina
- Gene therapy
- Gene editing (CRISPR)
- Tumors and gliomas
- In vivo studies
- Molecular biology
- Optic nerve regeneration
The de Lima Lab investigates neuroprotection and regeneration of cells in the retina responsible for carrying the information perceived by the eye all the way to the brain - the retinal ganglion cells (RGC) - focusing on the disease model for optic pathway gliomas caused by the genetic disorder Neurofibromatosis type 1 (NF1-OPG). Our aim is to investigate mechanisms that promote survival and regeneration of RGCs and explore therapeutic targets.